C12N 2710/16341
Use of virus, viral particle or viral elements as a vector
C12N2710/16341 (Use of virus, viral particle or viral elements as a vector) appears on 87 US grants and 70 published applications in this corpus.
Search patents in C12N- Granted patents
- 87
- Published applications
- 70
- Assignees
- 34
- Inventors
- 106
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 5 | 0 |
| 2001 | 6 | 1 |
| 2002 | 4 | 3 |
| 2003 | 2 | 2 |
| 2004 | 1 | 0 |
| 2005 | 2 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 2 | 2 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 3 |
| 2015 | 6 | 4 |
| 2016 | 1 | 2 |
| 2017 | 2 | 3 |
| 2018 | 1 | 7 |
| 2019 | 8 | 6 |
| 2020 | 9 | 4 |
| 2021 | 2 | 5 |
| 2022 | 5 | 6 |
| 2023 | 2 | 3 |
| 2024 | 1 | 4 |
| 2025 | 5 | 4 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/16343Viral genome or elements thereof as genetic vectorIndexing code87
- C12N 2710/16342Virus or viral particle as vehicleIndexing code0
- C12N 2710/16344Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2710/16345Special targeting system for viral vectorsIndexing code0
Recent patents
- Multivalent HVT vector vaccine31 Mar 2026US 12,589,147 B2Intervet Inc.
- Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens6 Jan 2026US 12,514,922 B2Intervet Inc.
- Recombinant herpesvirus of turkeys (HVT) and preparation method and use thereof6 Jan 2026US 12,516,353 B2Yangzhou University
- Recombinant viruses and the uses thereof9 Dec 2025US 12,491,242 B2Ceva Sante Animale
- Gallid alphaherpesvirus 3 (MDV-2), a viral vector against different avian pathogens: a new vaccination strategy in the poultry industry18 Nov 2025US 12,473,572 B1FarmacolóGicos Veterinarios S.A.C.
- Recombinant marek's disease virus and uses thereof2 Jul 2026US 2026/0183386 A1Ceva Sante Animale
- Recombinant Non-Pathogenic Marek's Disease Virus Constructs Encoding Infectious Laryngotracheitis Virus and Infectious Bursal Disease Virus Antigens22 Jan 2026US 2026/0021176 A1Intervet Inc.
- New multivalent hvt vector vaccine20 Nov 2025US 2025/0352642 A1Intervet Inc.
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof30 Oct 2025US 2025/0333766 A1Boehringer Ingelheim Animal Health USA Inc.
- Use of codon deoptimisation and optimisation to produce a laryngotracheitis virus-attenuated vaccine6 Mar 2025US 2025/0073331 A1Edge Animal Health, Inc.
Most cited
By later US patents
- Chicken interleukin-15 and uses thereof88US 6,737,522 B2Wayne State University · 2004
- Recombinant herpesvirus of turkeys and live vector vaccines derived thereof65US 5,470,734 AAkzo Nobel N. V. · 1995
- Newcastle disease virus combination vaccine59US 5,733,556 AAkzo Nobel N. V. · 1998
- Recombinant herpesvirus of turkeys comprising a foreign DNA inserted into a non-essential region of the herpesvirus of turkeys genome34US 6,121,043 ASyntro Corporation · 2000
- Recominbant Herpesvirus of Turkeys and live vector vaccines derived thereof32US 5,187,087 AAkzo N. V. · 1993